• GenVec Inc., of Gaithersburg, Md., extended a research collaboration and license agreement with Novartis AG, of Basel, Switzerland, in order to fund research at GenVec through January 2013 for hearing loss and balance disorders. The companies signed the original agreement in January 2010 for up to $213.6 million in up-front and milestone payments.